A Phase III Double-blind Randomized Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, Locally Advanced (Inoperable) or Metastatic Triple Negative Breast Cancer (TNBC)

Project: Research project

Project Details

Short titleCapivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC (CAPItello-290)
StatusActive
Effective start/end date1/1/19 → …

Funding

  • AstraZeneca